{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:36:27Z","timestamp":1789900587541,"version":"4.0.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T00:00:00Z","timestamp":1416960000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0113402","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T20:47:00Z","timestamp":1417034820000},"page":"e113402","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Towards Engineering Hormone-Binding Globulins as Drug Delivery Agents"],"prefix":"10.1371","volume":"9","author":[{"given":"Wee Lee","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy J.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.103.2675.409","article-title":"The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides","volume":"103","author":"A Gilman","year":"1946","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1158\/1078-0432.CCR-10-1277","article-title":"Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much?","volume":"16","author":"T Fojo","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1995.13.2.513","article-title":"Use of tamoxifen for breast cancer: twenty-eight years later","volume":"13","author":"IA Jaiyesimi","year":"1995","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3816\/CLC.2009.n.004","article-title":"Toxicity of targeted therapy in non-small-cell lung cancer management","volume":"10","author":"S Ricciardi","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1399-3011.1979.tb01730.x","article-title":"A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic","volume":"14","author":"H Maeda","year":"1979","journal-title":"Int J Pept Protein Res"},{"key":"ref6","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Y Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2008.11.010","article-title":"Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect","volume":"71","author":"H Maeda","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-3659(01)00309-1","article-title":"Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS","volume":"74","author":"H Maeda","year":"2001","journal-title":"J Control Release"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nbt0905-1073","article-title":"Monoclonal antibody successes in the clinic","volume":"23","author":"JM Reichert","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.addr.2012.05.013","article-title":"Risks and untoward toxicities of antibody-based immunoconjugates","volume":"64","author":"D Litvak-Greenfeld","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"PW Kantoff","year":"2010","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-10-3402","article-title":"Prostate cancer immunotherapy","volume":"17","author":"KF May","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMp1103057","article-title":"Listening to Provenge\u2014what a costly cancer treatment says about future Medicare policy","volume":"364","author":"JD Chambers","year":"2011","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/336257a0","article-title":"Hormone binding globulins undergo serpin conformational change in inflammation","volume":"336","author":"PA Pemberton","year":"1988","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0968-0004(85)90011-8","article-title":"\u03b1 1-Antitrypsin and the serpins: variation and countervariation","volume":"10","author":"R Carrell","year":"1985","journal-title":"Trends Biochem Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.84.15.5153","article-title":"Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors","volume":"84","author":"GL Hammond","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1021\/cr010170+","article-title":"Serpin structure, mechanism, and function","volume":"102","author":"PG Gettins","year":"2002","journal-title":"Chem Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"29594","DOI":"10.1074\/jbc.M705014200","article-title":"Corticosteroid-binding globulin, a structural basis for steroid transport and proteinase-triggered release","volume":"282","author":"MA Klieber","year":"2007","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jmb.2008.05.012","article-title":"The S-to-R transition of corticosteroid-binding globulin and the mechanism of hormone release","volume":"380","author":"A Zhou","year":"2008","journal-title":"Journal of Molecular Biology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1074\/jbc.M110.171082","article-title":"Allosteric modulation of hormone release from thyroxine and corticosteroid-binding globulins","volume":"286","author":"X Qi","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1210\/jc.2012-4280","article-title":"How Changes in Affinity of Corticosteroid-binding Globulin Modulate Free Cortisol Concentration","volume":"98","author":"WL Chan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/S0021-9258(18)89572-2","article-title":"Primary structure of the reactive site of human C1-inhibitor","volume":"260","author":"GS Salvesen","year":"1985","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4020-6316-9_4","article-title":"Processing diffraction data with mosflm","volume":"Vol. 245","author":"AGW Leslie","year":"2007","journal-title":"Evolving Methods for Macromolecular Crystallography"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"PR Evans","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1107\/S0907444910051218","article-title":"Improvement of molecular-replacement models with Sculptor","volume":"67","author":"G Bunk\u00f3czi","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"P Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix. refine","volume":"68","author":"PV Afonine","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2009.06.015","article-title":"Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin","volume":"316","author":"HY Lin","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0959-440X(01)00275-5","article-title":"Serpins and other covalent protease inhibitors","volume":"11","author":"S Ye","year":"2001","journal-title":"Curr Opin Struct Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1073\/pnas.162232399","article-title":"Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism","volume":"99","author":"TP Baglin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"I Schechter","year":"1967","journal-title":"Biochem Biophys Res Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation","volume":"30","author":"EW Davie","year":"1991","journal-title":"Biochemistry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJM198309223091203","article-title":"Mutation of Antitrypsin to Antithrombin","volume":"309","author":"MC Owen","year":"1983","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-410X.2006.06102.x","article-title":"Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology","volume":"97","author":"K McVary","year":"2006","journal-title":"BJU Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","article-title":"Androgens and estrogens in benign prostatic hyperplasia Past, present and future","volume":"82","author":"TM Nicholson","year":"2011","journal-title":"Differentiation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The link between benign prostatic hyperplasia and prostate cancer","volume":"10","author":"DD \u00d8rsted","year":"2013","journal-title":"Nat Rev Urol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"SP Balk","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2008.11.020","article-title":"Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: A step towards diagnosis of prostate cancer","volume":"403","author":"V Kumar","year":"2009","journal-title":"Clin Chim Acta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0014-5793(87)81151-1","article-title":"The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein","volume":"225","author":"K Akiyama","year":"1987","journal-title":"FEBS Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1074-5521(98)90004-7","article-title":"Substrate specificity of prostate-specific antigen (PSA)","volume":"5","author":"GS Coombs","year":"1998","journal-title":"Chem Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jsbmb.2011.08.006","article-title":"Corticosteroid-binding globulin reactive centre loop antibodies recognise only the intact natured protein: Elastase cleaved and uncleaved CBG may coexist in circulation","volume":"127","author":"JG Lewis","year":"2011","journal-title":"J. Steroid Biochem Mol Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e52759","DOI":"10.1371\/journal.pone.0052759","article-title":"Corticosteroid-binding globulin: structure-function implications from species differences","volume":"7","author":"BR Gardill","year":"2012","journal-title":"PLoS ONE"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0090-4295(78)90467-3","article-title":"Treatment of advanced cancer of prostate with megestrol acetate","volume":"12","author":"J Geller","year":"1978","journal-title":"Urology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pros.2990030103","article-title":"Acute therapy with megestrol acetate decreases nuclear and cytosol androgen receptors in human BPH tissue","volume":"3","author":"J Geller","year":"1982","journal-title":"Prostate"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0305-7372(89)90004-2","article-title":"Megestrol acetate: clinical experience","volume":"16","author":"L Schacter","year":"1989","journal-title":"Cancer Treatment Reviews"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<825::AID-CNCR13>3.0.CO;2-N","article-title":"A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181","volume":"88","author":"NA Dawson","year":"2000","journal-title":"Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.2042-7158.2012.01464.x","article-title":"Novel actions of progesterone: what we know today and what will be the scenario in the future?","volume":"64","author":"SN Kaore","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Heidenreich A, Aus G, Abbou CC, Bolla M, Joniau S, et al. (2008) Guidelines on Prostate Cancer: 1\u2013114.","DOI":"10.1016\/j.eururo.2007.09.002"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"IF Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-5793(78)80099-4","article-title":"Steroid-protein interactions. Kinetics of binding of cortisol and progesterone to human corticosteroid-binding globulin","volume":"86","author":"SD Stroupe","year":"1978","journal-title":"FEBS Lett"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00673709","article-title":"Corticosteroid-binding globulin. A review of some recent aspects","volume":"55","author":"U Westphal","year":"1983","journal-title":"Mol Cell Biochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"13321","DOI":"10.1073\/pnas.0604080103","article-title":"Structural mechanism for the carriage and release of thyroxine in the blood","volume":"103","author":"A Zhou","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0960-0760(94)90010-8","article-title":"Substitutions of tryptophan residues in human corticosteroid-binding globulin: impact on steroid binding and glycosylation","volume":"49","author":"GV Avvakumov","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/bj20020014","article-title":"Loop variants of the serpin thyroxine-binding globulin: implications for hormone release upon limited proteolysis","volume":"365","author":"H Grasberger","year":"2002","journal-title":"Biochem J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/protein\/gzr006","article-title":"Computational design of an endo-1, 4-beta-xylanase ligand binding site","volume":"24","author":"A Morin","year":"2011","journal-title":"Protein Eng Des Sel"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nprot.2013.074","article-title":"Small-molecule ligand docking into comparative models with Rosetta","volume":"8","author":"SA Combs","year":"2013","journal-title":"Nat Protoc"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e19230","DOI":"10.1371\/journal.pone.0019230","article-title":"De novo enzyme design using Rosetta3","volume":"6","author":"F Richter","year":"2011","journal-title":"PLoS ONE"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature12443","article-title":"Computational design of ligand-binding proteins with high affinity and selectivity","volume":"501","author":"CE Tinberg","year":"2013","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","article-title":"Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder","volume":"9","author":"DA Brooks","year":"2003","journal-title":"Trends in Molecular Medicine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jmb.2009.12.046","article-title":"Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions","volume":"396","author":"MJ Bernett","year":"2010","journal-title":"Journal of Molecular Biology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.addr.2009.07.014","article-title":"Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics","volume":"61","author":"S Nagata","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains","volume":"81","author":"SL Morrison","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/812742","article-title":"Reverse Genetics Modification of Cytomegalovirus Antigenicity and Immunogenicity by CD8 T-Cell Epitope Deletion and Insertion","volume":"2011","author":"NAW Lemmermann","year":"2011","journal-title":"Journal of Biomedicine and Biotechnology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0113402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T10:57:19Z","timestamp":1650711439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0113402"}},"subtitle":[],"editor":[{"given":"Ashley M.","family":"Buckle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,26]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0113402","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,26]]}}}